cover story
that price reduction is passed on to patients . He also said that the prices of all stocked stents will have to be revised according to the new ceiling price . The Minister laid stress that the landed price / manufacturing cost of imported BMS is Rs 5,415 and for DES is Rs 16,918 , hence the ceiling prices have been set taking into account the ethical profit margins and R & D costs of each member of the supply chain of coronary stents .
On the other hand , the AiMeD ’ s Rajiv Nath isn ’ t convinced . He says , “ Hospitals will start demanding credit notes for loss made on inventory they hold . Manufactures will be asked to pay penalty for not acting overnight . If importers and manufacturers go to court ultimately public and patient are the one who will suffer . Ideally the implementation should have been from a cut-off date and next batch . The requirement of all stocks in market to be sold at revised price is impractical and unreasonable . Laws and rules should be reasonable and easy to follow .”
Meanwhile the NPPA is
22 BioVoiceNews | March 2017